Entre em contato conosco
Leica DM1000 LED Clinical

Microscópio de sistema excepcionalmente ergonômico, agora disponível com a inovadora iluminação a LED Leica DM1000 LED

A Leica Microsystems apresenta a análise de imagem quantitativa Tissue IA 2.0*

Análise de fluorescência e campo claro para patologia digital

Wetzlar, Alemanha. A Leica Microsystems anuncia o lançamento do Tissue IA 2.0, análise de imagem de alta performance para pesquisa de descoberta. A combinação das capacidades de análise de fluorescência e de campo claro em uma única plataforma, com modelagem celular de precisão, faz com que o Tissue IA 2.0 ofereça uma solução superior para a quantificação de biomarcadores em IHC. O Tissue IA 2.0 entra no portfólio de patologia digital total da Leica, fornecendo excelência funcional de ponta a ponta na captura, gerenciamento e análise de imagens digitais de patologia.

Um grande desafio na pesquisa atual é a recuperação de dados quantitativos reprodutíveis dos estudos de IHC em tecido. O Tissue IA 2.0 fornece as ferramentas especializadas para que os pesquisadores extraiam o máximo dos seus estudos. A poderosa funcionalidade de separação por cores e co-localização de multimarcadores fornece percepções avançadas e medição imparcial da marcação de vários antígenos nas amostras em campo branco ou fluorescência. A modelagem sofisticada da célula detecta com precisão e quantifica a expressão de diferentes expressões em compartimentos celulares, fornecendo percepções detalhadas sobre a localização do no marcador citoplasmático, membrânico e nuclear.

As avançadas capacidades de coloração duplas no Tissue IA2.0 permitem que os pesquisadores identifiquem coortes de células a nível molecular. Utilize um marcador para identificar uma população de interesse e, em seguida, quantificar a expressão de uma segunda, proporcionando realização de análises excepcionais e maior compreensão de suas lâminas. Os algoritmos são facilmente ajustados e otimizados para diferentes marcadores, tecidos e protocolos, oferecendo uma plataforma flexível para aplicações de descobertas de drogas.

Fácil de implementar e fácil de usar, a interface do Tissue IA, que pode ser acessada através da internet, significa que o usuário pode levar suas análises consigo para onde for. Com capacidade de análises de lote com alto rendimento, o Tissue IA 2.0 irá processar lâminas inteiras, regiões de interesse ou núcleos de microarranjos de tecido e, automaticamente, integrar os resultados da análise a suas lâminas. Uma interface de carregamento integrada facilita a integração com algoritmos de soluções de software de terceiros, oferecendo maior flexibilidade para expandir ainda mais suas opções de análise.

Dr. Donal O’Shea, diretor de patologia digital da Leica Microsystems, declara: “O multiplex é cada vez mais importante na pesquisa translacional e ferramentas que ajudam a quantificar a expressão e localização de vários biomarcadores ao mesmo tempo no tecido são uma necessidade real. O TissueIA 2.0 é benéfico para o usuário, pois oferece quantificação e colocalização cromogênica e de fluorescência , histoscoring da coloração IHC multi-compartimental e o poder de incluir e excluir populações de células com base na expressão de biomarcadores. Em conjunção com as plataformas SCN400 F e Ariol, nosso portfólio de patologia digital é expandido ainda mais para o pesquisador de ciências da vida e clínico, além de demonstrar nosso comprometimento contínuo com esta área."

O Tissue IA 2.0, com sua análise potente e funcional, é a opção ideal para a descoberta de biomarcadores e pesquisas translacionais. Sua combinação exclusiva de flexibilidade, automação de facilidade de uso faz dele uma ferramenta sem igual para a pesquisa de patologia digital.

A Leica Microsystems estará presente no Encontro Anual da Associação Americana de Pesquisas contra o Câncer de 2012, de 21 de março a 4 de abril, em Chicago, IL. Visite a Leica no estande 4103 para experimentar nossa nova solução de análise de imagem para patologia digital.

*Para uso exclusivo em pesquisas. Não adequado para procedimentos de diagnóstico.

A Leica Microsystems apresenta o escaneamento de lâminas extra grandes para patologia digital em neurociência

Escaneamento de lâminas duplas e jumbo com o SCN400 da Leica

[Translate to portuguese:] Wetzlar, Germany. The largest capture area of any line scanner in digital pathology is now possible with the Leica SCN400 and SCN400 F. The latest release in Leica’s Total Digital Pathology portfolio enables the digitization of very large specimens, not possible with any other line scanning digital pathology system.

This development provides a new level of flexibility in digital pathology, enabling users to scan a wide range of samples on a single system. Traditional (26 x 76 mm), double (52 x 76 mm) and now extra-large Jumbo (113 x 76 mm) slides can all be captured in either brightfield or fluorescence using the Leica SCN400 and SCN400 F scanners.

Existing users of the Leica SCN400 digital slide scanner range can benefit from being able to implement large slide scanning, without any hardware changes or physical updates to their scanners.

To view some sample large slide scans, please visit our Virtual Slide Gallery at www.leica-microsystems.com/products/digital-pathology.

Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems says, “Line scanning in digital pathology has, until now, been limited to single and double slides. The introduction of extra-large slide scanning is a significant advancement for neuroscience, toxicological pathology and anyone dealing with large tissue sections. The cost and time saving benefits of sharing large tissue sections digitally rather than physically is a valuable tool for our users.”

Leica Microsystems’ Total Digital Pathology portfolio scanning range enables the capture of the widest range of sample types whether brightfield, fluorescence or FISH demon­strating Leica’s drive and innovation in this market. Leica Microsystems’ broad range of interoperable Digital Pathology components provides customers with the flexibility to choose the solution that is right for their needs.

Experience Leica Microsystems’ Total Digital Pathology solutions at booth 2825 during the Society for Neuroscience annual meeting, from November 12-16 in Washington, DC.

  • <media 45065 - - "TEXT, 111102 PR Leica Jumbo Slide en, 111102_PR_Leica_Jumbo_Slide_en.doc, 167 KB">Press Release Leica Jumbo Slide (English)</media>
  • <media 45064 - - "TEXT, 111102 PR Leica Jumbo Slide de, 111102_PR_Leica Jumbo Slide_de.doc, 166 KB">Press Release Leica Jumbo Slide (German)</media>

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.

Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

A Leica Microsystems apresenta solução completa para gerenciamento de caso para patologia digital na Pathology Visions

Integrando a patologia digital com os fluxos de trabalho clínicos atuais

[Translate to portuguese:] Wetzlar, Germany. Leica Microsystems announce the launch of its clinical workflow solution for Digital Pathology at Pathology Visions 2011. Digital Image Hub Enterprise* with its powerful image manage­ment, integration and communication capabilities, in conjunction with a new high performance, intuitive client viewer, SlidePath Gateway*, combine to make this the ideal solution for clinical centers moving towards true Digital Pathology implementation. Furthermore, Leica’s Total Digital Pathology solutions now provide an implementation of the DICOM Supplement 145 standard for both slide scanning and viewing.

Flexible case aggregation capabili­ties in Digital Image Hub Enterprise utilizes slide barcodes to identify and automatically consolidate multiple slides within a case into a worklist. The system can then automatically associate the slides with appropriate case information by querying the laboratory information management system (LIMS), thus presenting both case information and digital slides concurrently. These compre­hensive and flexible communica­tion specifications enable seamless integration of Digital Pathology with world-leading anatomical pathology LIS providers, such as Cerner CoPath Plusand Sunquest (formerly Elekta) PowerPath, as well as additional 3rd party and bespoke systems via the inbuilt flexible Integration Toolkit.

The user-friendly interface and flexible reporting tools in SlidePath Gateway Client enable anatomical pathologists to follow the cases from slide scanning right through to reporting.

For access on the move, pathologists can view their digital slides through multiple modalities including Internet Browsers and iPad, giving anytime, anywhere access to cases for rapid second opinion or fro­zen section review. Access to real time conferencing capability allows users to consult on cases with their peers on demand. Technical controls, to help facilitate HIPAA compliance, enable users and system administrators to be assured of the security and integrity of clinical data.

To download your free copy of the SlidePath Gateway Client Viewer and access example cases on Digital Image Hub Enterprise, please visit www.leica-microsystems.com/products/digital-pathology.

Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems says, “This is a big step for Leica Microsystems in building out our Digital Pathology technology portfolio. Providing an Enterprise level infrastructure for Digital Pathology that facilitates the delivery of an ergonomic, high performance, easy to use, clinical case management workflow was central to our product development strategy. This is optimally engineered to allow users to leverage Digital Pathology where it delivers real ROI in the clini­cal setting. We will continue to innovate aggressively across our technology portfolio to ensure a best in class position in Digital Pathology in clinical, research and educational areas.”

Leica Microsystems are exclusive platinum sponsors of Pathology Visions 2011, October 30 – November 2, San Diego, CA. Visit Leica at booth 302 – 304 to see our complete case management solutions for Digital Pathology.

* For Research use only. Not for use in diagnostic procedures.

  • <media 44795 - - "TEXT, 111024 PR Leica Digital Pathology Case Management en, 111024_PR_Leica_Digital_Pathology_Case_Management_en.doc, 168 KB">Press Release Case Management Solution (English)</media>
  • <media 45067 - - "TEXT, 111102 PR Leica Case Management de, 111102_PR_Leica_Case_Management_de.doc, 167 KB">Press Release Case Management Solution (German)</media>

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise. Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory. The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

A Leica Microsystems é patrocinadora platina do workshop da Sociedade de hematopatologia / Associação Europeia de Hematopatologia (SH/EAHP) 2011

Levando a excelência de patologia digital ao workshop de patologia

[Translate to portuguese:] Wetzlar, Germany / Los Angeles, USA. Leica Microsystems, world-leading providers of Total Digital Pathology solutions, are a proud platinum sponsor of this year’s joint workshop of the Society for Hematopathology and the European Association for Haematopathology (SH/EAHP) being held at the Ritz-Carlton Marina Del Rey, Los Angeles, USA, from October 27-29, 2011.

With a record number of case submissions and registered delegates, this year’s SH/EAHP Workshop promises to be an exciting meeting for physicians who are interested in the field of “Cutaneous Lymphomas and Their Mimics”, the topic of the Workshop. In addition to an impressive agenda of presentations from world-leading experts, attendees of the Workshop will be able to access cases for review online before, during and after the meeting.

From over 300 cases submitted to the Workshop, 120 have been selected by the Workshop Panel for inclusion in the Workshop Book. Attendees will be able to access scanned slides of these 120 cases via the internet using Leica Microsystems’ digital pathology educational software, SlidePath Digital SlideBox. The scanned images are high resolution scans of the whole glass slides generated using the Leica SCN400. Furthermore, the Workshop attendees can view PowerPoint and Word documents files of all submitted and accepted cases on the Workshop Case Server, providing rich content for the Workshop discussions.

The Workshop attendees with iPads will be able to access and review the high resolution scans of the glass slides through Leica Microsystems’ digital pathology application, SlidePath Gateway.

Dr. Sophie Song, Organizing Committee Chair, SH/EAHP Workshop 2011 says, “We are very happy to have Leica Microsystems as one of our platinum sponsors for this event. The image quality of the Leica SCN400 scanned slides coupled with the ease of use of Digital SlideBox makes Leica’s Total Digital Pathology system ideal for supporting our workshop. Attendees will really benefit from being able to readily access the cases, either through their internet browser or on the iPad.”

Registered attendees will receive information on how to access the Workshop Case Server through both Digital SlideBox and the iPad.

For non-attendees, sample images of the Leica SCN400 digital slide scanner can be seen in the Virtual Slide Gallery at www.leica-microsystems.com/products/digital-pathology/ or by downloading SlidePath Gateway from the Apple app store.

  • <media 43859 - - "TEXT, 110915 PR Leica SH Workshop en, 110915_PR_Leica_SH_Workshop_en.doc, 108 KB">Press Release Platinum Sponsor SH/EAHP Workshop (English)</media>
  • <media 43858 - - "TEXT, 110915 PR Leica SH Workshop de, 110915_PR_Leica_SH_Workshop_de.doc, 108 KB">Press Release Platinum Sponsor SH/EAHP Workshop (German)</media>

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.

Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

Webinar: Soluções de patologia totalmente digital para pesquisa farmacêutica

Nesta apresentação, Olga Colgan irá tratar do uso da patologia digital como uma ferramenta para acelerar o progresso na descoberta e validação do biomarcador no domínio farmacêutico / CRO.

Faça o download do quarto webinar da nossa série de patologia digital, do qual chamamos atenção do uso do Leica SCN400 e do software integrado para pesquisa farmacêutica.

Com a crescente adoção de soluções de imagiologia de lâmina inteira em pesquisas farmacêuticas, a Leica Microsystems fornece um conjunto flexível de soluções para atender estas necessidades. Tanto o escaneamento FISH e de campo claro serão tratados, além de fluxos de trabalho de gerenciamento intuitivo e ferramentas para a expressão do biomarcador quantitativo em análise de lâmina inteira e TMA.

A Leica Microsystems lança o escaneador de lâminas SCN400 F com fluorescência e campo luminoso combinados

Digitalização fluorescente multicanal para patologia digital

[Translate to portuguese:] Wetzlar, Germany. Leica Microsystems announces the release of the Leica SCN400 F combined fluo­rescent and brightfield digital slide scanner. The SCN400 F brings together Leica’s award winning brightfield slide scanning capabilities and multi-channel fluorescence imaging in a single platform, providing versatility to researchers and core laboratories utilizing Digital Pathology.

By employing two separate illumination and scanning methods, the Leica SCN400 F ensures excellent brightfield scans and crisp multi-channel fluorescent images from one device. Scanned slides are readily re­viewed online through the SlidePath Digital Image Hub web-viewer, incorporating the ability to turn on and off separate channels with the click of a button to examine each marker individually.

To view a sample fluorescent image, please visit our Virtual Slide Gallery at www.leica-microsystems.com/products/digital-pathology.

Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems says, “The Leica SCN400 F is a significant breakthrough for researchers looking for an affordable solution for scanning brightfield and fluorescent slides. With the ever growing adoption of immunofluorescent staining in research to study multi-marker co-expression in oncology and neuroscience, we see the SCN400 F as a valuable tool for core laboratories, bringing increased efficiency and quality to research practices.”

The Leica SCN400 F is the newest scanning solution in the Total Digital Pathology portfolio, demon­strating Leica’s drive and innovation in this market. Leica Microsystems’ broad range of interoperable Digital Pathology components provides customers with the flexibility to choose the solution that is right for their needs.

  • <media 42261 - - "TEXT, 110705 PR Leica SCN400 F en new, 110705_PR_Leica_SCN400_F_en_new.doc, 301 KB">Press Release Leica SCN400 F (English)</media>
  • <media 42410 - - "TEXT, 110712 PR Leica SCN400 F de, 110712_PR_Leica_SCN400_F_de.doc, 298 KB">Press Release Leica SCN400 F (German)</media>

 

To view a sample fluorescent image, please visit our Virtual Slide Gallery at www.leica-microsystems.com/products/digital-pathology.

 

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.

Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology labo­ratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is head­quartered in Wetzlar, Germany.

Leica Microsystems lança app de patologia digital grátis para iPad e iPhone

O SlidePath Gateway agora disponível para download

[Translate to portuguese:] Wetzlar, Germany. Leica Microsystems announces the release of the SlidePath Gateway application for iPad and iPhone, which is the latest addition to the Total Digital Pathology portfolio. SlidePath Gateway is a Digital Pathology viewing application with built-in educational content from leading institutes and pathologists. The free application is available now for download from the Apple App store.

SlidePath Gateway provides access to high quality whole slide images captured on the Leica SCN400 slide scanner, with expert review findings and content provided by contributing bodies including:

  • ASCP CheckPath Anatomical Pathology EQA Program (2006)
  • Cerviva Cervical Cytology EQA Pilot (2009)
  • NHS Breast Screening Pathology EQA Program (2010)
  • UK National Urologic Pathology EQA Program (2009)
  • UKNEQAS HER2 Breast Interpretive EQA Pilo (2011)

Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems says, “The release of the SlidePath Gateway App displays Leica Microsystems’ commitment to develop and expand its Digital Pathology portfolio. With this App we are giving everyone the opportunity to try Digital Pathology, access high resolution whole slide images and expert opinions, through a highly intuitive user interface. With the rapid adoption and acceptance of iPads and other tablet devices in hospitals and clinical settings, we see SlidePath Gateway paving the way for future adoption of Digital Pathology in routine use.”

SlidePath Gateway for the iPad puts Digital Pathology at your fingertips. Users who install the application can browse folders of images from each of the External Quality Assessment (EQA) programs, select individual cases and view, zoom and navigate around the slides. Each case includes expert pathologist assessments, which can be viewed with the slides, giving increased insight into the samples. They can also see a sample set of Leica Biosystems’ Novocastra antibody range.

Existing users of Leica Microsystems’ Digital Pathology management solution, SlidePath Digital Image Hub (DIH), who usually access their system via a standard internet browser, can now securely connect to their own DIH library of images and review them through the application.

Building on a strong reputation for providing high quality, easy-to-use systems, SlidePath Gateway demonstrates Leica’s drive to deliver cutting edge, flexible tools to the Digital Pathology market.

  • <media 42151 - - "TEXT, 110628 PR Slide Path Gateway ipad App en, 110628_PR_SlidePath_Gateway_ipadApp_en.doc, 55 KB">Press Release Leica SlidePath Gateway (English)</media>
  • <media 42152 - - "TEXT, 110628 PR Slide Path Gateway i Pad App de, 110628_PR_SlidePath_Gateway_iPad_App_de.doc, 55 KB">Press Release Leica SlidePath Gateway (German)</media>

 

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.

Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

Primeira série de webinars sobre soluções digitais para patologia

Durante os últimos 12 meses, a Leica Microsystems integrou o software SlidePath em seu portfólio para oferecer uma solução de patologia digital completa, incluindo escaneamento rápido e de alta resolução da lâmina toda com um software de aplicação líder mundial.

A primeira das nossas séries de webinars sobre patologia digital ocorreu de 25 a 27 de janeiro de 2011 com o maior sucesso. Consistiu em três apresentações diferentes, em que foram abordados o uso do SCN400 da Leica e software integrado para pesquisa, análise remota de lâminas e educação. Os webinars foram gravados e podem ser transferidos por download do site da Leica Microsystems.

Clique aqui para fazer o download dos webinars.

Leica Microsystems vence o concurso europeu de digitalização

Primeiro lugar em velocidade de digitalização e imagens com melhor foco

[Translate to portuguese:] Vilnius, Lithuania / Wetzlar, Germany. Leica Microsystems‘ Slide Scanner Leica SCN400 and Autoloader Leica SL801 have come first in two categories of the first European Scanner Contest (ESC). The prizes were awarded in the “Scan Speed and Best-Focused Images” categories, each at 20x and 40x magnification.

The jury was convinced by the digital pathology system by Leica Microsystems: Thanks to the patented “Dynamic Focus”, the Slide Scanner Leica SCN400 produces virtual images of exceptional quality at unprecedented speed. Another product designed for high throughput in the pathology lab is the Autoloader Leica SL801, which is capable of scanning up to 384 samples at a time. “By winning first prize, Leica Microsystems has again asserted its market position. We will continue to play a key role in shaping the future of virtual microscopy and digital pathology,” said Dr. Bodo Falke, Sales Manager Central Europe for Leica Microsystems, at the award presentation in Vilnius, which hosted the 10th European Congress on Telepathology and the 4th International Conference on Virtual Microscopy last week.

The European Scanner Contest was held within the framework of “Pathology Week“, a joint event of the German Society of Pathology and the Association of German Pathologists. With this competition, the organizers have created the first opportunity to compare the speed and imaging quality of different scanners using identical samples. The contest is also intended to promote the development of virtual microscopy products.

  • <media 31640 - download>Press Release Scanner Contest (English)</media>
  • <media 31639 - download>Press Release Scanner Contest (German)</media>

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

Leica Microsystems is a leading global designer and producer of innovative, high-tech, precision optical systems for the analysis of microstructures. It is one of the market leaders in each of its business areas: Microscopy, Confocal Laser Scanning Microscopy with corresponding Imaging Systems, Specimen Preparation, and Medical Equipment. The company manufactures a broad range of products for numerous applications requiring microscopic imaging, measurement, and analysis.

It also offers system solutions for life science including biotechnology and medicine, research and development of raw materials, and industrial quality assurance. The company is represented in over 100 countries with 14 manufacturing facilities in 11 countries, sales and service organizations in 19 countries and an international network of dealers. The international management is headquartered in Wetzlar, Germany.

Leica Microsystems adquire o portfólio de tecnologias de fortalecimento das ciências da vida da Genetix

A Genetix agora é parte da Leica Microsystems, uma líder global no desenvolvimento e produção de tecnologias ópticas.

[Translate to portuguese:] New Milton, Hampshire, UK/Wetzlar, Germany. Genetix Ltd, a leading provider of solutions for imaging and image analysis, has been acquired by Leica Microsystems. This acquisition brings together Genetix’ expertise in developing and marketing imaging systems and software for clinical and research applications, with Leica Microsystems’ microscopes and other life science instrumentation. The merger will enable both companies to fully realize their potential through the combination of their ideally complemented skill sets.

Genetix will exist as a separate business unit within Leica Microsystems and Genetix products will continue to be marketed and sold through existing channels. Customer services such as product ordering, applications support and instrument service for Genetix products will remain unchanged.

Commenting on the acquisition Charles de Rohan, Head of Genetix Business Unit within Leica Microsystems, said: “Joining together with Leica Microsystems gives Genetix greater access to global markets and increased financial resources to achieve its growth plans. Over the past decade Genetix has been building its presence in the life sciences, diagnostics and digital pathology segments through a combination of internal product development and acquisitions. Combining our strengthening presence with Leica Microsystems’ R&D capabilities, greater resources and global reach is in the best interests of our shareholders, customers and employees and will maximize the potential of our innovative technology. I would like to take this opportunity to thank all our customers for their continued support."

Stefan Traeger, Managing Director Life Science Division, Leica Microsystems, said: "Genetix’ extensive expertise will be invaluable for us. Their software capabilities, specifically in analytical software, will help us to make progress in the area of virtual microscopy, which is a field we have only recently stepped into. In addition, Genetix’ experience and market leading products in cell biology and genetics will expand our reach into the drug discovery and development markets.”

  • <media 28609 - download>Press Release Acquisition Genetix (English)</media>
  • <media 28610 - download>Press Release Acquisition Genetix (German)</media>
  • More about Genetix Ltd.